Mycotic infections in the immunocompromised patient

Revista Iberoamericana de Micologia

Volumn 13, Issue SUPPL. 1, 1996, Pages

  Rüchel, Reinhard ^a,b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b Hygiene Institut   (Germany)

Author keywords

Diagnosis; Etiology; Immunocompromised patient; Invasive mycoses; Synoptical consideration

Indexed keywords

EID: 0008229435     PISSN: 11301406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Anaissie E Opportunistic mycoses in the immunocompromised host Experience at a cancer center and review Clin Infec Dis, 1992, 14: 43-53
2. Pfaffenbach B Donhuijsen K, Pahnke J, Bug R, Adamek R.J, Wegener M, Ricken D Deep mycoses accompanying haematological neoplasia. A post mortem analysis of 1 053 patients Med Klin 1994, 89:299-304
3. Guiot H F L, Fibbe W E, van't Wout J W Risk factors for fungal infection in patients with malignant hematologic disorders Implications for empirical therapy and prophylaxis. Clin Infect Dis, 1994, 18: 525-532
4. Hibberd P L, Rubin R H Clinical aspects of fungal infection in organ transplant recipients. Clin Infect Dis, 1994; 19:33-40
5. Kwon-Chung K J, Bennett J E Medical Mycology Lea & Febiger, Philadelphia 1992
6. Pfaller M, Cabezudo I, Koontz F, Bale M, Gingrich R, Predictive value of surveillance cultures for systemic infection due to Candida species Eur J Clim Microbiol 1987; 6 628-633
7. Mackowiak P A The normal microbial flora N Engl J Med 1982; 307:33-93
8. Daw M A, Munnelly P, McCann S R, Daly P A, Falkiner F R, Keane C T Value of surveillance cultures in the management of neutropenic patients Eur J Clin Microbiol Infect Dis, 1988; 7 742-747
9. Eng R H K, Bishburg E, Smith S W, Mangia A Fungemia observations of peripheral tissue clearane in humans J Med Vet Mycol, 1992; 30:471-475
10. Telenti A, Roberts DGD Fungal blood cultures Eur J clin Microbiol Infect Dis, 1989, 8 825-831.
11. Khatib R, Clark J A, Briski L E, Wilson F M Relevance of culturing Candida species from intravascular catheters J Clin Microbiol, 1995, 33 1635-1637.
12. Rüchel R, Margraf S Rapid microscopical diagnosis of deep-seated mycoses following maceration of fresh specimens and staining with optical brighteners Mycoses, 1993; 36 239-242.
13. Ruchel R Diagnosis of invasive mycoses in severely immunosuppressed patients Ann Hematol, 1983; 67:1-11
14. Muller J, Kappe R, Kubitza D, Fessler R Scheidecker I Incidence of deep-seated mycoses in Freiburg i Br. Federal, Republic of Germany Mykosen 1987, 30 9-28
15. Edwards J E. Invasive Candida infections Evolution of a pathogen N Engl J Med, 1991, 324:1060-1062
16. Wingard J R Merz W G, Saral R Candida tropicalis A major pathogen in immunocompromised patients Ann Intern Med, 1979; 91 539-543
17. Horn R, Wong B, Kiehn T E, Armstrong D. Fungemia in a cancer hospital Changing frequency, earlier onset, and results of therapy Rev Infect Dis 1985, 7:646-655
18. Bodey G P, Anaissie E J Chronic systemic candidiasis Eur J Clin Microbiol Infect Dis, 1989, 8 855-857
19. Loeliger A, van Leeuwen M, Rozenberg-Arska M, Dekker A W Hepatosplenic candidiasis, a fatal disease? Infections 1992, 20 336-338
20. Edwards J E Should all patients with candidemia be treated with antifungat agents? Clin Infect Dis, 1992, 15 422-423
21. Rozenbaum R, Goncalves A J R Clinical epidemiological study of 171 cases of cryptococcosis. Clin Infect Dis, 1994 18 369-380
22. Clark R A, Greer D, Atkinson W, Valainis G T, Hyslop N Spectrum of Cryptococcus neoformans infection in 68 parents infected with human immunodeficiency virus. Rev Infect Dis, 1990; 12:768-777
23. Ruhnke M, Eigler A, Tennagen I, Geiseler B, Engelmann E Trautmann M Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection. J Clin Microbiol, 1994, 32 2092-2098
24. De Pauw B E Raemaekers J M M, Donelly J P, Kullberg B J, Meis J F G M An open study on the safety and efficacy of fluconazole in the treatment of disseminated Candida infections in patients treated for hematological malignancy. Ann Hermatol 1995 70:83-87
25. Bodey G P, Vartivarian S Aspergillosis Eur J Clin Microbiol Infect Dis, 1989, 8:413-437
26. Dupont B, Denning D W, Marriott D, Sugar A, Viviani M A, Sirisanthana T Mycoses in AIDS patients J Med Vet Mycol 1994, 32 1 65-77
27. Sugar A M Mucormycosis Clin Infect Dis, 1992; 14 1 126-129
28. Aucott J N, Fayen J, Grossnicklas H, Morrissey A, Lederman M M, Salata R A Invasive infection with Saccharomyces cerevisiae. Report of three cases and review Rev Infect Dis, 1990 12:406-411
29. Pfaller M, Wenzel R Impact of the changing epidemiology of fungal infections in the 1990s Eur J Clin Microbiol Infect Dis, 1992, 11 287-291
30. Vartivarian S E, Anaissie E J, Bodey G P Emerging fungal pathogens in immunocompromised patients: Classification, diagnosis, and management. Clin Infect Dis, 1993, 17 487-491
31. Cunliffe N A, Denning D W Uncommon invasive mycoses in AIDS AIDS, 1995; 9:411-420
32. Anaissie E, Kantarjian H, Ro J, Hopfer R, Rolston K, Fainstein V, Bodey G The emerging role of Fusarium infections in patients with cancer. Medicine, 1988, 67 77-83
33. Thompson GP, Roberts G D Pseudoallescheriasis In Fungal Diseases of the Lung, 2nd ed , G A Sarosi, S F Davies (eds) Raven Press, New York 1993 171-180
34. Tashiro T Nagai H , Kamberi P, Goto Y, Kikuchi H, Nasu M, Akizuki S Disseminated Trichosporon beigelii infection in patients with malignant diseases: Immunohistochemical study and review. Eur J Clin Microbiol Infect Dis, 1994, 13:218-224.
35. Debusk C H, Daoud R, Thirumoorthi M C, Wilson F M, Khatib R Candidemia: Current epidemiologic characteristics and a long-term follow-up of the survivors. Scand J Infect Dis 1994, 26:697-703
36. Bodey G P The potential role of granulocyte-macrophage colony stimulating factor in therapy of fungal infections A commentary. Eur J Clin Microbiol Infect Dis 1994 13 363-366